 | Up a level |
2022
Jannes, Marcus, Koenig, Alexander, Kolben, Martin, Fridrich, Claudius and Kirn, Verena (2022). Staging for Breast Cancer: A Nationwide Survey about Adherence to Guidelines in German Breast Centers. Breast Care, 17 (3). S. 316 - 321. BASEL: KARGER. ISSN 1661-3805
2018
Chekerov, Radoslav, Hilpert, Felix, Mahner, Sven, El-Balat, Ahmed, Harter, Philipp, De Gregorio, Nikolaus, Fridrich, Claudius, Markmann, Susanne, Potenberg, Jochem, Lorenz, Ralf, Oskay-Oezcelik, Guelten, Schmidt, Marcus 
ORCID: 0000-0003-1365-2414, Krabisch, Petra, Lueck, Hans-Joachim, Richter, Rolf, Braicu, Elena Ioana, du Bois, Andreas and Sehouli, Jalid
(2018).
Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol., 19 (9).
S. 1247 - 1259.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488
2016
Diehl, Anja, Volland, Ruth, Kirn, Verena, Thangarajah, Fabinshy, Eichler, Christian, Einzmann, Thomas, Wirtz, Marina, Ratiu, Dominik, Morgenstern, Bernd, Fridrich, Claudius, Mallmann, Peter and Puppe, Julian (2016). The number of removed lymph nodes by inguinofemoral lymphadenectomy: impact on recurrence rates in patients with vulva carcinoma. Arch. Gynecol. Obstet., 294 (1). S. 131 - 137. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-0711
2014
Kirn, Verena, Shi, Rong, Heublein, Sabine, Knabl, Julia, Guenthner-Biller, Margit, Andergassen, Ulrich, Fridrich, Claudius, Malter, Wolfram, Harder, Jan, Friese, Klaus, Mayr, Doris and Jeschke, Udo (2014). Estrogen receptor promoter methylation predicts survival in low-grade ovarian carcinoma patients. J. Cancer Res. Clin. Oncol., 140 (10). S. 1681 - 1688. NEW YORK: SPRINGER. ISSN 1432-1335